- Trials with a EudraCT protocol (27)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
27 result(s) found for: Dehydration.
Displaying page 1 of 2.
EudraCT Number: 2016-005165-31 | Sponsor Protocol Number: LPS14914 | Start Date*: 2020-05-14 | |||||||||||
Sponsor Name:Sanofi Aventis Groupe | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter, Comparative Study to Assess the Efficacy and Safety of Spores of Enterogermina in Combination with Oral Rehydration Ther... | |||||||||||||
Medical condition: Acute diarrhea | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000367-25 | Sponsor Protocol Number: AURIGA | Start Date*: 2019-04-17 | |||||||||||
Sponsor Name:FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO | |||||||||||||
Full Title: Acute effect of parenteral rehydration solution commonly used in children with acute gastroenteritis on acid-base balance, free-fatty acids metabolism and glucose homeostasis | |||||||||||||
Medical condition: Dehydration and metabolic acidosis due to acute gastroenteritis | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004621-40 | Sponsor Protocol Number: NL50760 | Start Date*: 2015-09-07 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: The effect of oral ondansetron on referral rate in children aged 6 months to 6 years attending in primary care out of hours service with acute gastro-enteritis and vomiting. | ||
Medical condition: Gastroenteritis | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003582-25 | Sponsor Protocol Number: NL59128 | Start Date*: 2017-01-23 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: The added effect of oral ondansetron to care-as-usual on persisting vomiting in children aged 6 months to 6 years, presenting at primary care out of hours service with acute gastro-enteritis and co... | ||
Medical condition: Gastroenteritis | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002291-13 | Sponsor Protocol Number: DIALAGG | Start Date*: 2012-10-19 | |||||||||||
Sponsor Name:InfectoPharm - Arzneimittel und Consilium GmbH | |||||||||||||
Full Title: Multicentre, prospective, double-blind, two-armed, placebo-controlled phase III study to evaluate the efficacy and safety of the treatment of diarrhoea with Lactobacillus rhamnosus GG (InfectoDiarr... | |||||||||||||
Medical condition: Acute diarrhoea in infants and toddlers | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002923-24 | Sponsor Protocol Number: R033812GTS3001 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Prospective Study to Evaluate the Safety and Efficacy of Domperidone in 6-month-old to 12-year-old Pediatric Subjects Wi... | |||||||||||||
Medical condition: Nausea and Vomiting Due to Acute Gastroenteritis | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) PT (Completed) BE (Completed) ES (Prematurely Ended) AT (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000483-29 | Sponsor Protocol Number: Wada_2012 | Start Date*: 2013-07-17 | |||||||||||
Sponsor Name:Bispebjerg Hospital | |||||||||||||
Full Title: The influence of exercise and hydration to the pharmacological response to inhaled terbutalin and salbutamol in men | |||||||||||||
Medical condition: To investigate the pharmacokinetic effect of the medicine under physical work in healthy men | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003943-30 | Sponsor Protocol Number: VomED | Start Date*: 2005-11-22 | |||||||||||
Sponsor Name:University of Leipzig | |||||||||||||
Full Title: Doubleblind randomized multicenter trial to investigate the influence of dimenhydrinate suppositories vs. placebo on oral rehydration in infants and children with infectious enteritis and vomiting | |||||||||||||
Medical condition: Infectious enteritis with vomiting | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002601-19 | Sponsor Protocol Number: OND-URG | Start Date*: 2019-09-16 |
Sponsor Name:Basque Health Service | ||
Full Title: Effectiviness and safety of the administration of ondansetron versus placebo for the treatment of vomit in children with mild and moderate dehydration: randomized clinical trial | ||
Medical condition: Vomiting | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005700-15 | Sponsor Protocol Number: marha1983 | Start Date*: 2013-01-07 |
Sponsor Name:Lennart Svensson Linköping University Medical Faculty | ||
Full Title: Can 5-HT3 receptor antagonists be used to limit vomiting in rota- and norovirus infections? | ||
Medical condition: Virus caused vomiting and effect of the antiemetic drug Ondansetron | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004444-30 | Sponsor Protocol Number: Disc_allo_MSV | Start Date*: 2013-04-23 |
Sponsor Name:Citospin | ||
Full Title: Treatment of degenerative disc disease with allogenic mesenchymal cells—MSV-- | ||
Medical condition: Treatment of degenerative disc disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-000439-27 | Sponsor Protocol Number: CL0600-005 | Start Date*: 2007-10-29 |
Sponsor Name:NPS Allelix Corporation | ||
Full Title: A Study of the Safety and Efficacy of Teduglutide in Subjects with Parenteral Nutrition-Dependant Short Bowel Syndrome Who Completed Protocol CL0600-004 | ||
Medical condition: Short Bowel Syndrome (SBS) refers to the clinical situation whereby a significant reduction in the absorptive capacity of the intestine results from inadequate anatomical or functional length of re... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-002156-84 | Sponsor Protocol Number: 63623872FLZ3001 | Start Date*: 2018-05-08 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, a... | |||||||||||||
Medical condition: Influenza A Infection | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) LV (Prematurely Ended) LT (Prematurely Ended) FR (Prematurely Ended) DE (Prematurely Ended) SK (Prematurely Ended) BE (Completed) CZ (Prematurely Ended) NL (Prematurely Ended) ES (Prematurely Ended) HU (Prematurely Ended) BG (Prematurely Ended) PL (Prematurely Ended) GB (Prematurely Ended) AT (Prematurely Ended) IT (Prematurely Ended) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003212-22 | Sponsor Protocol Number: 10MI30 | Start Date*: 2013-06-03 | |||||||||||
Sponsor Name:GOSH/ICH Joint Research & Development Office | |||||||||||||
Full Title: Phase I study of ex-vivo lentiviral gene therapy for the inherited skin disease Netherton Syndrome | |||||||||||||
Medical condition: Netherton Syndrome (NS) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001776-21 | Sponsor Protocol Number: NCT00687882 | Start Date*: 2016-03-10 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für | ||
Full Title: Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children | ||
Medical condition: Thrombosis in pediatric patients | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Completed) NL (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2020-002023-11 | Sponsor Protocol Number: 53718678RSV3001 | Start Date*: 2021-02-16 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rilematovir in Infants and Children (≥28 Days to ≤5 Years of Age) and Subsequently in Neonates (... | |||||||||||||
Medical condition: Respiratory Syncytial Virus | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) DE (Prematurely Ended) SE (Completed) CZ (Completed) HU (Completed) BE (Completed) PL (Completed) Outside EU/EEA EE (Completed) LV (Completed) SK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020797-41 | Sponsor Protocol Number: NEMO1-08NR26 | Start Date*: 2010-11-16 | |||||||||||
Sponsor Name:Only for Children Pharmaceuticals | |||||||||||||
Full Title: NEMO-1: An open label exploratory dose finding and pharmacokinetic clinical trial of bumetanide for the treatment of NEonatal seizure using Medication Off-patent. | |||||||||||||
Medical condition: Neonatal Seizures in Hypoxic Ischemic Encephalopathy | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) FI (Prematurely Ended) GB (Prematurely Ended) SE (Prematurely Ended) FR (Ongoing) NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003642-93 | Sponsor Protocol Number: 53718678RSV2002 | Start Date*: 2018-12-05 | ||||||||||||||||
Sponsor Name:Janssen Sciences Ireland UC | ||||||||||||||||||
Full Title: A Phase 2, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Relationships of Different Doses o... | ||||||||||||||||||
Medical condition: Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) BE (Completed) ES (Prematurely Ended) HU (Completed) SE (Completed) FR (Completed) DE (Prematurely Ended) PL (Completed) BG (Completed) Outside EU/EEA IT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-000473-39 | Sponsor Protocol Number: CIR-ILI-2014 | Start Date*: 2015-01-19 | |||||||||||
Sponsor Name:Fundacio Parc Taulí | |||||||||||||
Full Title: Randomized and prospective clinical trial about the therapeutic use of diatrizoic acid (Gastrografin®) in postoperative ileus. | |||||||||||||
Medical condition: Postoperative paralytic Ileus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003774-27 | Sponsor Protocol Number: BC-180-12 | Start Date*: 2014-01-20 |
Sponsor Name:AlgiPharma AS | ||
Full Title: An open label, randomised, two-way crossover scintigraphic study to investigate lung deposition of radiolabelled OligoG delivered as a dry powder and as a nebulised solution in cystic fibrosis pati... | ||
Medical condition: Cystic fibrosis (CF) is an autosomal, recessive inheritable disease caused by a homozygote defect at the long arm of Chromosome 7. This mutation causes absence or defect of the cystic fibrosis tran... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
